Arrowstreet Capital’s Traws Pharma TRAW Stock Holding History

Arrowstreet Capital’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1	Closed	-$935K	–	1377
2013 Q4	$935K	Buy	+1	New	+$947K	0.01%	839

Other funds holding TRAW

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowstreet Capital's TRAW Position: Q1 2014 in Review

Arrowstreet Capital sold out of Traws Pharma (TRAW) in Q1 2014, closing a stake of 1 share — an estimated $935K sold.

Arrowstreet Capital first reported a position in TRAW in Q4 2013 and held it in 1 quarter. The position peaked at $935K in Q4 2013. 16 funds tracked by Wall St. Rank hold TRAW as of Q1 2014.

Arrowstreet Capital reported no remaining Traws Pharma position as of Q1 2014 after selling out during the quarter.
Arrowstreet Capital sold 1 Traws Pharma share in Q1 2014, an estimated $935K.
Arrowstreet Capital first reported a position in Traws Pharma in Q4 2013 and held it in 1 quarter.
Arrowstreet Capital's Traws Pharma position peaked at $935K in Q4 2013.
16 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2014.

Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.